IL139144A0 - Mycobacterial inhibitors - Google Patents
Mycobacterial inhibitorsInfo
- Publication number
- IL139144A0 IL139144A0 IL13914499A IL13914499A IL139144A0 IL 139144 A0 IL139144 A0 IL 139144A0 IL 13914499 A IL13914499 A IL 13914499A IL 13914499 A IL13914499 A IL 13914499A IL 139144 A0 IL139144 A0 IL 139144A0
- Authority
- IL
- Israel
- Prior art keywords
- mycobacterial
- mycobacterial inhibitors
- inhibitors
- treatment
- certain
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical class O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN969MA1998 | 1998-05-05 | ||
| SE9802118A SE9802118D0 (sv) | 1998-06-15 | 1998-06-15 | Mycobacterial inhibitors |
| PCT/SE1999/000732 WO1999065483A1 (en) | 1998-05-05 | 1999-05-03 | Mycobacterial inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL139144A0 true IL139144A0 (en) | 2001-11-25 |
Family
ID=26324850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13914499A IL139144A0 (en) | 1998-05-05 | 1999-05-03 | Mycobacterial inhibitors |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6476053B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1075261B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002518324A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20010043322A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1201735C (cg-RX-API-DMAC10.html) |
| AT (1) | ATE322898T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU739140B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR9910185A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2330667A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE69930844T2 (cg-RX-API-DMAC10.html) |
| IL (1) | IL139144A0 (cg-RX-API-DMAC10.html) |
| NO (1) | NO20005548L (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ507620A (cg-RX-API-DMAC10.html) |
| WO (1) | WO1999065483A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2060259B1 (en) | 2001-11-01 | 2010-01-20 | Spectrum Pharmaceuticals, Inc. | Medical compositions for intravesical treatment of bladder cancer |
| KR20080034944A (ko) * | 2005-08-19 | 2008-04-22 | 아스트라제네카 아베 | 결핵 치료용 피라졸론 유도체 |
| GB0520368D0 (en) * | 2005-10-06 | 2005-11-16 | Univ Aston | Antibacterial pyrrols |
| WO2010063617A1 (de) * | 2008-12-04 | 2010-06-10 | Basf Se | Mischungen aus itaconsäure oder itaconsäurederivaten und primären aminen zur herstellung von 1,3- und 1,4-alkylmethylpyrrolidonen |
| PL3393530T3 (pl) * | 2015-12-23 | 2022-12-05 | Henkel Ag & Co. Kgaa | Płyn do obróbki metali |
| CN107033060B (zh) * | 2017-05-04 | 2020-01-14 | 浙江工业大学 | 一种n-取代顺丁烯二酰亚胺类化合物及其制备与抗菌应用 |
| CN111465611B (zh) * | 2017-12-01 | 2024-10-11 | 古德T细胞有限公司 | 预防或治疗脱发的组合物 |
| CN119569636B (zh) * | 2024-10-22 | 2026-03-27 | 南京吉星生物技术开发有限公司 | 一种吡咯啉二酮类化合物及其制备方法和杀菌剂应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3883342A (en) * | 1973-04-13 | 1975-05-13 | Akzona Inc | Plant growth regulators |
-
1999
- 1999-05-03 AU AU43041/99A patent/AU739140B2/en not_active Ceased
- 1999-05-03 CA CA002330667A patent/CA2330667A1/en not_active Abandoned
- 1999-05-03 KR KR1020007012290A patent/KR20010043322A/ko not_active Ceased
- 1999-05-03 AT AT99957018T patent/ATE322898T1/de not_active IP Right Cessation
- 1999-05-03 JP JP2000554363A patent/JP2002518324A/ja active Pending
- 1999-05-03 IL IL13914499A patent/IL139144A0/xx unknown
- 1999-05-03 US US09/331,623 patent/US6476053B1/en not_active Expired - Fee Related
- 1999-05-03 NZ NZ507620A patent/NZ507620A/en unknown
- 1999-05-03 BR BR9910185-8A patent/BR9910185A/pt not_active Application Discontinuation
- 1999-05-03 DE DE69930844T patent/DE69930844T2/de not_active Expired - Fee Related
- 1999-05-03 WO PCT/SE1999/000732 patent/WO1999065483A1/en not_active Ceased
- 1999-05-03 CN CNB99808283XA patent/CN1201735C/zh not_active Expired - Fee Related
- 1999-05-03 EP EP99957018A patent/EP1075261B1/en not_active Expired - Lifetime
-
2000
- 2000-11-03 NO NO20005548A patent/NO20005548L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ507620A (en) | 2003-05-30 |
| AU739140B2 (en) | 2001-10-04 |
| AU4304199A (en) | 2000-01-05 |
| DE69930844D1 (de) | 2006-05-24 |
| CA2330667A1 (en) | 1999-12-23 |
| CN1201735C (zh) | 2005-05-18 |
| NO20005548L (no) | 2000-12-04 |
| EP1075261B1 (en) | 2006-04-12 |
| CN1308532A (zh) | 2001-08-15 |
| NO20005548D0 (no) | 2000-11-03 |
| WO1999065483A1 (en) | 1999-12-23 |
| US6476053B1 (en) | 2002-11-05 |
| EP1075261A1 (en) | 2001-02-14 |
| DE69930844T2 (de) | 2006-12-28 |
| KR20010043322A (ko) | 2001-05-25 |
| ATE322898T1 (de) | 2006-04-15 |
| BR9910185A (pt) | 2001-01-09 |
| JP2002518324A (ja) | 2002-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901514A0 (en) | Pyrazolopyrimidinone cgmp PDE5 inhibitors for the treatment of sexual disfunction | |
| WO2001044247A3 (en) | Agents and methods for the treatment of proliferative diseases | |
| YU15299A (sh) | Farmaceutski sastavi | |
| MY135732A (en) | 5,6-trimethylenepyrimidin - 4 - one compounds | |
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| BG105270A (en) | Tetrahydropyridoethers | |
| MY138285A (en) | Fab i inhibitors | |
| SG148031A1 (en) | Use of cci-779 as an antineoplastic agent | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| BR9809185A (pt) | Diidropiranos fundidos | |
| IT1285770B1 (it) | Composti corticoidei | |
| AU2002248269A1 (en) | Use of p38 inhibitors for the treatment of inflammation-enhanced cough | |
| AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
| GB9804886D0 (en) | Therapeutic combination | |
| SE9802937D0 (sv) | Novel compounds | |
| MXPA01010403A (es) | Agentes quimiotacticos e inhibidores derivados de osteopontina y usos de los mismos. | |
| NZ330451A (cg-RX-API-DMAC10.html) | ||
| PT971922E (pt) | Compostos de tetra-hidropirido | |
| AU4179399A (en) | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders | |
| GB9907571D0 (en) | Compounds | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| TR200103125T2 (tr) | Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| MXPA02011558A (es) | Inhibidores de mmp-2/mp-9 novedosos. | |
| AU2576901A (en) | Agents and methods for the treatment of proliferative diseases |